SHINEWAY PHARM: Notification Letter to Non-registered Shareholders - Notice of Publication of 2023 Annual Report, Circular and Environmental, Social and Governance Report 2023
SHINEWAY PHARM: Notification Letter to Registered Shareholders - Notice of Publication of 2023 Annual Report, Circular, Proxy Form and Environmental, Social and Governance Report 2023
SHINEWAY PHARM: ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023
SHINEWAY PHARM: Form of proxy for use at the annual general meeting to be held on Friday, 31 May 2024 (or at any adjournment thereof)
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
SHINEWAY PHARM: First interim dividend in respect of the fiscal year 2024
SHINEWAY PHARM: NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS WITH REPLY FORM - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS
SHINEWAY PHARM: NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS WITH REPLY FORM - ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
SHINEWAY PHARM: TURNOVER FOR THE NINE MONTHS ENDED 30 SEPTEMBER 2023
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
SHINEWAY PHARM: RESIGNATION OF EXECUTIVE DIRECTOR
SHINEWAY PHARM: List of Directors and their Role and Function
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
SHINEWAY PHARM: Second interim dividend in respect of the fiscal year 2023
SHINEWAY PHARM: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
No Data